Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
1
10%
Ph not_applicable
9
90%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
unknown1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (10.0%)
N/A9 (90.0%)

Trials by Status

unknown110%
completed770%
terminated110%
withdrawn110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10